These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38889905)

  • 21. The clinical use of Fondaparinux: A synthetic heparin pentasaccharide.
    Zhang Y; Zhang M; Tan L; Pan N; Zhang L
    Prog Mol Biol Transl Sci; 2019; 163():41-53. PubMed ID: 31030756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the pharmacological properties and clinical results of the synthetic pentasaccharide (fondaparinux).
    Samama MM; Gerotziafas GT
    Thromb Res; 2003 Jan; 109(1):1-11. PubMed ID: 12679126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombelastography versus AntiFactor Xa levels in the assessment of prophylactic-dose enoxaparin in critically ill patients.
    Van PY; Cho SD; Underwood SJ; Morris MS; Watters JM; Schreiber MA
    J Trauma; 2009 Jun; 66(6):1509-15; discussion 1515-7. PubMed ID: 19509608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa.
    Siddiqui F; Tafur A; Bontekoe E; Iqbal O; Jeske W; Mehrotra S; Hoppensteadt D; Ramacciotti E; Fareed J
    Clin Appl Thromb Hemost; 2020; 26():1076029619895120. PubMed ID: 31914798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of anti-factor Xa activity in critically ill COVID-19 patients receiving three different anticoagulation regimens.
    Hamad MA; Dasuqi SA; Aleem A; Omran RA; AlQahtani RM; Alhammad FA; Alzeer AH
    SAGE Open Med; 2021; 9():20503121211049931. PubMed ID: 34659762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparin Anti-Xa Activity, a Readily Available Unique Test to Quantify Apixaban, Rivaroxaban, Fondaparinux, and Danaparoid Levels.
    Boissier E; Senage T; Babuty A; Gouin-Thibault I; Rozec B; Roussel JC; Sigaud M; Ternisien C; Trossaert M; Fouassier M; Lakhal K
    Anesth Analg; 2021 Mar; 132(3):707-716. PubMed ID: 32833716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-Factor Xa Activity of Fixed-Dose Fondaparinux in Low-Body-Weight Patients With Acute Coronary Syndrome.
    Wongcharoen W; Tantisirivit N; Norasetthada L; Gunaparn S; Phrommintikul A
    Ann Pharmacother; 2020 Nov; 54(11):1083-1089. PubMed ID: 32462894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Is monitoring of anti-factor Xa levels required for low molecular weight heparin prophylaxis of venous thromboembolism in critically ill patients?].
    Ding M; Ning Y; Song L; Li P; Xie F; Li S; Wang C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 May; 36(5):461-464. PubMed ID: 38845490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioactivity of enoxaparin in critically ill patients with normal renal function.
    Gouya G; Palkovits S; Kapiotis S; Madl C; Locker G; Stella A; Wolzt M; Heinz G
    Br J Clin Pharmacol; 2012 Nov; 74(5):806-14. PubMed ID: 23227470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New pentasaccharides for prophylaxis of deep vein thrombosis: pharmacology.
    Bauer KA
    Chest; 2003 Dec; 124(6 Suppl):364S-370S. PubMed ID: 14668419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fondaparinux, a synthetic pentasaccharide: the first in a new class of antithrombotic agents - the selective factor Xa inhibitors.
    Bauer KA; Hawkins DW; Peters PC; Petitou M; Herbert JM; van Boeckel CA; Meuleman DG
    Cardiovasc Drug Rev; 2002; 20(1):37-52. PubMed ID: 12070533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of venous thromboembolism in hospitalized acutely ill medical patients: focus on the clinical utility of (low-dose) fondaparinux.
    Di Nisio M; Porreca E
    Drug Des Devel Ther; 2013; 7():973-80. PubMed ID: 24068866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fondaparinux: a new antithrombotic agent.
    Cheng JW
    Clin Ther; 2002 Nov; 24(11):1757-69; discussion 1719. PubMed ID: 12501872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Future therapeutic directions for factor Xa inhibition in the prophylaxis and treatment of thrombotic disorders.
    Turpie AG
    Am J Health Syst Pharm; 2003 Nov; 60(22 Suppl 7):S20-4. PubMed ID: 14650863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a Rapid Qualitative Screen for Anticoagulant Presence.
    Wong S; Slingerland J; Dickerson JA; Pak J; Roach GD; Saifee NH
    J Appl Lab Med; 2024 Mar; 9(2):305-315. PubMed ID: 38101950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fondaparinux: a synthetic heparin pentasaccharide as a new antithrombotic agent.
    Walenga JM; Jeske WP; Samama MM; Frapaise FX; Bick RL; Fareed J
    Expert Opin Investig Drugs; 2002 Mar; 11(3):397-407. PubMed ID: 11866668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fondaparinux in a critically Ill patient with heparin-induced thrombocytopenia: A case report.
    He Y; He H; Liu D; Long Y; Su L; Cheng W
    Medicine (Baltimore); 2018 Sep; 97(37):e12236. PubMed ID: 30212955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fondaparinux for prevention of venous thromboembolism in major orthopedic surgery.
    Tran AH; Lee G
    Ann Pharmacother; 2003 Nov; 37(11):1632-43. PubMed ID: 14565815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functionality of fondaparinux (pentasaccharide) depends on clinical antithrombin levels.
    Jeske WP; Walenga JM; Samama MM; Hoppensteadt D; Mayuga M; Fareed J
    Blood Coagul Fibrinolysis; 2011 Apr; 22(3):206-10. PubMed ID: 21297455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The EFFORT trial: Preoperative enoxaparin versus postoperative fondaparinux for thromboprophylaxis in bariatric surgical patients: a randomized double-blind pilot trial.
    Steele KE; Canner J; Prokopowicz G; Verde F; Beselman A; Wyse R; Chen J; Streiff M; Magnuson T; Lidor A; Schweitzer M
    Surg Obes Relat Dis; 2015; 11(3):672-83. PubMed ID: 25620436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.